RIOK2
Serine/threonine-protein kinase RIO2
Also known as: FLJ11159, RIOK2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BVS4
- Gene
- RIOK2
- Ensembl
- ENSG00000058729
- Chromosome
- 5
- Canonical length
- 552 aa
- Protein class
- Enzymes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
Predicted to enable protein kinase activity. Involved in several processes, including positive regulation of rRNA processing; positive regulation of ribosomal small subunit export from nucleus; and regulation of mitotic metaphase/anaphase transition. Located in cytoplasm. Part of preribosome, small subunit precursor. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
552 residues, UniProt reviewed canonical sequence.
>Q9BVS4|RIOK2
1 MGKVNVAKLR YMSRDDFRVL TAVEMGMKNH EIVPGSLIAS IASLKHGGCN KVLRELVKHK
61 LIAWERTKTV QGYRLTNAGY DYLALKTLSS RQVVESVGNQ MGVGKESDIY IVANEEGQQF
121 ALKLHRLGRT SFRNLKNKRD YHKHRHNVSW LYLSRLSAMK EFAYMKALYE RKFPVPKPID
181 YNRHAVVMEL INGYPLCQIH HVEDPASVYD EAMELIVKLA NHGLIHGDFN EFNLILDESD
241 HITMIDFPQM VSTSHPNAEW YFDRDVKCIK DFFMKRFSYE SELFPTFKDI RREDTLDVEV
301 SASGYTKEMQ ADDELLHPLG PDDKNIETKE GSEFSFSDGE VAEKAEVYGS ENESERNCLE
361 ESEGCYCRSS GDPEQIKEDS LSEESADARS FEMTEFNQAL EEIKGQVVEN NSVTEFSEEK
421 NRTENYNRQD GQRVQGGVPA GSDEYEDECP HLIALSSLNR EFRPFRDEEN VGAMNQYRTR
481 TLSITSSGSA VSCSTIPPEL VKQKVKRQLT KQQKSAVRRR LQKGEANIFT KQRRENMQNI
541 KSSLEAASFW GELocalizationUniProt · AlphaFold · HPA
Whether an antibody against RIOK2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 20 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 20 nTPM
- skeletal muscle: 20 nTPM
- retina: 18 nTPM
- liver: 17 nTPM
- pancreas: 16 nTPM
- heart muscle: 16 nTPM
Single-cell type
- pancreatic acinar cells: 40 nCPM
- oocytes: 37 nCPM
- erythrocyte progenitors: 36 nCPM
- extravillous trophoblasts: 35 nCPM
- pdcs: 35 nCPM
- plasma cells: 32 nCPM
Immune cell
- naive CD8 T-cell: 37 nTPM
- MAIT T-cell: 35 nTPM
- naive CD4 T-cell: 34 nTPM
- T-reg: 32 nTPM
- memory CD4 T-cell: 32 nTPM
- intermediate monocyte: 31 nTPM
Brain region
- cerebellum: 22 nTPM
- white matter: 20 nTPM
- hypothalamus: 18 nTPM
- cerebral cortex: 17 nTPM
- choroid plexus: 17 nTPM
- thalamus: 17 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.7
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.85
- DepMap mean gene effect
- -0.98
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- maturation of SSU-rRNA
- positive regulation of rRNA processing
- protein autophosphorylation
- regulation of mitotic metaphase/anaphase transition
- ribosomal small subunit biogenesis
- positive regulation of ribosomal small subunit export from nucleus
Molecular functions
- ATP binding
- metal ion binding
- protein kinase activity
- protein serine kinase activity
- protein serine/threonine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RIO kinase
- Protein kinase-like domain superfamily
- RIO-type domain
- RIO kinase, conserved site
- Winged helix-like DNA-binding domain superfamily
- Winged helix DNA-binding domain superfamily
- RIO domain
- RIO2 kinase winged helix domain, N-terminal
- Serine/threonine-protein kinase Rio2
- Rio2, N-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RIOK2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RIOK2 as an antibody target. Whether an autoantibody or antibody against RIOK2 could matter depends on whether native RIOK2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RIOK2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RIOK2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...